Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estrogen for Quality-of-Life and Immune Modulation in Prostate Cancer (EQUIP)

NCT07466498 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT07466498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07466498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estrogen for Quality-of-Life and Immune Modulation in Prostate Cancer (EQUIP)
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
June 1, 2029
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-sensitive prostate adenocarcinoma, metastatic castration-sensitive prostate adenocarcinoma, stage ivb prostate cancer ajcc v8